Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer

Table 1 Clinicopathologic characteristics and AT-rich interactive domain 1A expression in 209 patient samples of colorectal cancer n (%)

Characteristics	Value
Gender
Male	176 (84.2)
Female	33 (15.8)
Age (yr)
Median	55
Range	19-88
Tumor location
Colon	111 (53.1)
Rectal	98 (46.9)
TNM stage (AJCC)
I	35 (16.7)
II	48 (23.0)
III	55 (26.3)
IV	71 (34.0)
T stage
T1	10 (4.8)
T2	35 (16.7)
T3	53 (25.4)
T4	111 (53.1)
N stage
N0	98 (46.9)
N1	56 (26.8)
N2	55 (26.3)
M stage
M0	138 (66.0)
M1	71 (34.0)
Pathologic differentiation
Poor	36 (17.2)
Moderate	148 (70.8)
Well	25 (12.0)
Tumor size (cm)
≤ 5	136 (65.1)
> 5	73 (34.9)
Expression of ARID1a
Negative	54 (25.8)
Positive	155 (74.2)

AJCC: American Joint Committee on Cancer; TNM: Tumor-node-metastasis; ARID1A: AT-rich interactive domain 1A.